VANCOUVER, British Columbia, Aug. 27, 2026 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced details pertaining to an operational efficiency plan (the “Plan”) expected to drive profitability and cash flow as first referenced on August 21, 2026, during its fiscal Q3 conference call.
Originally published via Source Article.
VANCOUVER, British Columbia, Aug. 27, 2026 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced details pertaining to an operational efficiency plan (the “Plan”) expected to drive profitability and cash flow as first referenced on August 21, 2026, during its fiscal Q3 conference call.
Originally published via Source Article.
TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today reported financial results and provided an operational update for the fiscal quarter ended June 30, 2026 (“Fiscal Q3 2026”).
Originally published via Source Article.
TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today reported financial results and provided an operational update for the fiscal quarter ended June 30, 2026 (“Fiscal Q3 2026”).
Originally published via Source Article.
TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today reported financial results and provided an operational update for the fiscal quarter ended June 30, 2026 (“Fiscal Q3 2026”).
Originally published via Source Article.
TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today reported financial results and provided an operational update for the fiscal quarter ended June 30, 2026 (“Fiscal Q3 2026”).
Originally published via Source Article.
TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today reported financial results and provided an operational update for the fiscal quarter ended June 30, 2026 (“Fiscal Q3 2026”).
Originally published via Source Article.
VANCOUVER, British Columbia, Aug. 27, 2026 (GLOBE NEWSWIRE) — Aldebaran Resources Inc. (TSX-V: ALDE, OTCQX: ADBRF) (“Aldebaran”) and its former subsidiary Centauri Minerals Inc. (TSX-V: CENT) (“Centauri” and together with Aldebaran, the “Companies”) are pleased to announce that they have completed the previously announced plan of arrangement (the “Arrangement”) pursuant to which Aldebaran spun out 18,544,058 common shares of Centauri (“Centauri Shares”) held by Aldebaran to its shareholders of record as at the close of business on August 26, 2026 (the “Aldebaran Shareholders”) 18,544,058 common shares of Centauri (“Centauri Shares”) held by Aldebaran.
CALGARY, Alberta, Aug. 26, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that its Board of Directors has approved the grant of an aggregate of 7,715,900 stock options and 3,981,900 restricted share units to certain directors, officers, employees and consultants pursuant to the Company’s Option Plan and RSU/DSU Plan approved by shareholder at the AGM held on February 19, 2026. A total of 6,188,600 options and 3,484,200 restricted share units were granted to insiders. A total of 4,210,000 options expired since the previous granting of options on September 30, 2025.
Originally published via Source Article.
CALGARY, Alberta, Aug. 26, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that its Board of Directors has approved the grant of an aggregate of 7,715,900 stock options and 3,981,900 restricted share units to certain directors, officers, employees and consultants pursuant to the Company’s Option Plan and RSU/DSU Plan approved by shareholder at the AGM held on February 19, 2026. A total of 6,188,600 options and 3,484,200 restricted share units were granted to insiders. A total of 4,210,000 options expired since the previous granting of options on September 30, 2025.
Originally published via Source Article.
